S J Kilty1, A Lasso2, L Mfuna-Endam3, M Y Desrosiers3. 1. Department of Otolaryngology - Head and Neck Surgery, The University of Ottawa, Ottawa, Canada. 2. The Ottawa Hospital Research Institute (OHRI), Ottawa, Canada. 3. Department of Otolaryngology, Hotel-Dieu Hospital, Centre de Recherche du Centre Hospitalier de l Universite de Montreal (CRCHUM), Montreal, Canada.
Abstract
INTRODUCTION: Endoscopic Polypectomy In Clinic (EPIC) is a recently described deescalated form of endoscopic sinus surgery (ESS) performed in the outpatient clinic for patients with chronic rhinosinusitis with polyps (CRSwNP). The quality of life benefit of EPIC in comparison to ESS is not known. The purpose of this study was to determine if the disease specific quality of life measured with the SNOT-22 attained with EPIC is similar to that attained with ESS for patients with CRSwNP. METHODS: A multi-institutional observational case-control study was performed to evaluate quality of life improvement in patients treated with ESS and EPIC for CRSwNP with a 3 month follow-up. Predicted probability of undergoing EPIC was calculated by fitting a logistic regression model using clinically relevant variables. EPIC patients were matched to ESS patients in a 1:1 fashion. RESULTS: 24 pairs were analyzed after matching. There was no statistical difference in the post-treatment SNOT-22 scores or proportion of patients achieving a minimal clinically important difference. CONCLUSIONS: In appropriate CRSwNP patients, the EPIC procedure may provide disease specific quality of life improvement similar to that seen with patients who undergo traditional ESS.
INTRODUCTION: Endoscopic Polypectomy In Clinic (EPIC) is a recently described deescalated form of endoscopic sinus surgery (ESS) performed in the outpatient clinic for patients with chronic rhinosinusitis with polyps (CRSwNP). The quality of life benefit of EPIC in comparison to ESS is not known. The purpose of this study was to determine if the disease specific quality of life measured with the SNOT-22 attained with EPIC is similar to that attained with ESS for patients with CRSwNP. METHODS: A multi-institutional observational case-control study was performed to evaluate quality of life improvement in patients treated with ESS and EPIC for CRSwNP with a 3 month follow-up. Predicted probability of undergoing EPIC was calculated by fitting a logistic regression model using clinically relevant variables. EPIC patients were matched to ESSpatients in a 1:1 fashion. RESULTS: 24 pairs were analyzed after matching. There was no statistical difference in the post-treatment SNOT-22 scores or proportion of patients achieving a minimal clinically important difference. CONCLUSIONS: In appropriate CRSwNP patients, the EPIC procedure may provide disease specific quality of life improvement similar to that seen with patients who undergo traditional ESS.
Authors: L Klimek; S Becker; R Buhl; A M Chaker; T Huppertz; T K Hoffmann; S Dazert; T Deitmer; U Förster-Ruhrmann; H Olze; J Hagemann; S K Plontke; H Wrede; W Schlenter; H J Welkoborsky; B Wollenberg; A G Beule; C Rudack; S Strieth; R Mösges; C Bachert; T Stöver; C Matthias; A Dietz Journal: Laryngorhinootologie Date: 2020-05-08 Impact factor: 1.057
Authors: Wytske J Fokkens; Valerie Lund; Claus Bachert; Joaquim Mullol; Leif Bjermer; Jean Bousquet; Giorgio W Canonica; Lauren Deneyer; Martin Desrosiers; Zuzana Diamant; Joseph Han; Enrico Heffler; Claire Hopkins; Roger Jankowski; Guy Joos; Andrew Knill; Jivianne Lee; Stella E Lee; Gert Mariën; Benoit Pugin; Brent Senior; Sven F Seys; Peter W Hellings Journal: Allergy Date: 2019-07-15 Impact factor: 13.146
Authors: Shaun Kilty; Kednapa Thavorn; Arif Janjua; John Lee; Kristian MacDonald; Eric Meen; Damian Micomonaco; Brian Rotenberg; Leigh J Sowerby; Marc Tewfik; Susan Adams; Hubert Frenette; Andrea Lasso; Dean A Fergusson Journal: BMJ Open Date: 2020-12-02 Impact factor: 2.692
Authors: Ludger Klimek; Ulrike Förster-Ruhrmann; Achim G Beule; Adam M Chaker; Jan Hagemann; Felix Klimek; Ingrid Casper; Tilman Huppertz; Thomas K Hoffmann; Stefan Dazert; Thomas Deitmer; Heidi Olze; Sebastian Strieth; Holger Wrede; Wolfgang W Schlenter; Hans-Jürgen Welkoborsky; Barbara Wollenberg; Christoph Bergmann; Mandy Cuevas; Caroline Beutner; Moritz Gröger; Sven Becker Journal: Allergo J Date: 2022-09-05